drugset / Trial / NCT03541252
Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study
NaSingle-groupOpen-labelTreatment
Summary
A prospective clinical, uncontrolled, open-label, explorative phase IIa trial on patients with histologically- confirmed superficial and nodular basal cell carcinoma (BCC) . The study assesses tolerability and tumor clearance after laser-assisted topical delivery of two synergistic chemotherapeutic agents, cisplatin and 5-fluorouracil (5-FU) in BCC patients.
Timeline
- Start
- 2018-03-09
- Primary completion
- 2019-09-02
- Completion
- 2019-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 0.1 % | Topical |
| Subject | Cisplatin | Other / unclassified | 0.25 ml | Topical |
| Subject | fluorouracil | Small molecule | 0.125 ml | Topical |
| Subject | fluorouracil | Small molecule | 5 % | Topical |